Donate
Public Comment Period Open

Make 340B Work for Patients

The Health Resources and Services Administration (HRSA) is seeking public input on a potential 340B rebate model. Patients deserve transparency and a clear benefit from these savings.

Docket No. HRSA-2026-03042 | Deadline: March 19, 2026
Takes less than 5 minutes.
Submit Your Comment
Download the Toolkit
Tablet with Regulations.gov open
Woman typing at a computer
Why This Matters

Patients Should Benefit from 340B Savings

The 340B Drug Pricing Program allows certain hospitals and healthcare providers to purchase outpatient medications at significant government-mandated discounts.

The program was created to help covered entities stretch resources and serve more patients.

Yet many patients continue to face high deductibles, coinsurance, and out-of-pocket costs at the pharmacy counter. Patients are often not informed when a medication was acquired under 340B pricing, and there is limited visibility into how those savings are used.

The Health Resources and Services Administration (HRSA) is now evaluating whether a rebate model could change how those discounts are administered and tracked.

This is an opportunity to help ensure the program delivers measurable, transparent benefit for patients.

Button Text Here
How the Model Works

What Is the Proposed Rebate Model?

Hospitals purchase drugs at a discount. There is limited transparency into how those savings are used. Patients are not told when they receive a 340B drug.

Instead of upfront discounts, manufacturers would issue rebates tied to actual patient claims. This increases tracking and oversight.

When discounts are linked to claims data, it becomes clearer whether any savings benefit patients at the pharmacy counter or remain within hospital systems.

The Health Resources and Services Administration (HRSA) is asking for public input on how this model should be designed, put into practice, and monitored.

What Should You Include in Your Comment?

You do not need to be a policy expert.

What You Can Share:

  • Your experience paying for hospital-prescribed medication

  • Whether you have ever been told you received a 340B drug

  • Concerns about medical bills or out-of-pocket costs

  • Why transparency and accountability matter to you

Keep it simple. Personal stories matter.